Prolonged HIV suppression is possible using ibalizumab, analysis of highly drug-resistant patients shows

A treatment regimen containing ibalizumab (Trogarzo), a monoclonal antibody designed to block HIV, led to substantial viral load reductions in a majority of highly treatment-experienced people with few treatment options left, Dr Zvi Cohen of Theratechnologies reported at the International Congress on Drug Therapy in HIV Infection (HIV Glasgow) on Wednesday. Fifteen out of 40… Read More »

Weekly Roundup for NOVEMBER 2, 2018: Recent Publications in Women’s Mental Health

Uguz and colleagues present data that indicate, in a group of women with panic disorder, neonatal outcomes were worse in the women who did not get treatment.  This week’s roundup also features a lot of articles on postpartum depression, addressing an array of factors which increase women’s vulnerability to postpartum psychiatric illness, including adverse life… Read More »

Big Family, Small Risk of Cancer

Did you grow up in a large family with several siblings? You may remember a lot of chaos, jockeying for your parents’ attention, and complaints about wearing hand-me-downs, but there was probably a lot of love and companionship as well. While that somewhat crowded upbringing might have taught you some questionable life skills—such as eating… Read More »